US Female Infertility Market and Competitive Landscape to 2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 5, 2018--The “US Female Infertility Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.
US Female Infertility Market and Competitive Landscape - 2018, provides comprehensive insights into Female Infertility pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Female Infertility market size and drug sales. This research also provides insights into Female Infertility epidemiology and late stage pipeline.
The research is classified into the following sections - Female Infertility overview with definitions, symptoms, etiology, diagnosis, treatment options; Female Infertility pipeline insights covering late stage clinical trials pipeline; Female Infertility prevalence trends by countries; Female Infertility market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes the market - USA.
Research Scope:Female Infertility pipeline: Find out the drugs in clinical trials for Female Infertility by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Female Infertility epidemiology: Find out the prevalence of Female Infertility in US; prevalence forecast to 2023 Female Infertility products: Identify key products marketed and prescribed for Female Infertility by brand name, by molecule, by company, by branded / generic, in US Female Infertility market size: Find out the market size for Female Infertility drugs in US; Find out how the market advanced from 2014 Female Infertility drug sales: Find out the sales of Female Infertility drugs in US Female Infertility drugs sales forecast: Sales forecast for Female Infertility drugs to 2023 in US Female Infertility market share analysis: Find out the market shares of Female Infertility drugs and outlook in US
For more information about this report visit https://www.researchandmarkets.com/research/v5287j/us_female?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181005005342/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Women’s Health,Sexual and Reproductive Health Drugs
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: WOMEN HEALTH CLINICAL TRIALS PHARMACEUTICAL CONSUMER
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/05/2018 10:57 AM/DISC: 10/05/2018 10:57 AM